letter · Blood Research

Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report

20233 citationsOpen accessUniversity of Tunis El Manar

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Acute Myeloid Leukemia Research
Hematopoietic Stem Cell Transplantation
Acute Lymphoblastic Leukemia research

Sustainable Development Goals

Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.5045/br.2023.2023061

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.